Michael Donegan
2019
In 2019, Michael Donegan earned a total compensation of $572.1K as Vice President - Finance at TherapeuticsMD, a 19% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $72,500 |
|---|---|
| Option Awards | $193,787 |
| Salary | $290,000 |
| Other | $15,797 |
| Total | $572,084 |
Donegan received $290K in salary, accounting for 51% of the total pay in 2019.
Donegan also received $72.5K in non-equity incentive plan, $193.8K in option awards and $15.8K in other compensation.
Rankings
In 2019, Michael Donegan's compensation ranked 11,358th out of 13,971 executives tracked by ExecPay. In other words, Donegan earned more than 18.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,358 out of 13,971 | 19th |
Division Manufacturing | 4,606 out of 5,701 | 19th |
Major group Chemicals And Allied Products | 1,813 out of 2,200 | 18th |
Industry group Drugs | 1,560 out of 1,886 | 17th |
Industry Pharmaceutical Preparations | 1,154 out of 1,398 | 18th |
Pay ratio
| Michael Donegan's Pay | $572,084 |
|---|---|
| Median Employee's Pay | $114,000 |
| Pay Ratio | 5to 1 |
In 2019, the annual total compensation of Michael Donegan was $572,084.
The annual total compensation of the median employee at TherapeuticsMD was $114,000.
The ratio of Michael Donegan's pay to the pay of median employee was therefore 5 to one.
Source: SEC filing on May 4, 2020.
Donegan's colleagues
We found four more compensation records of executives who worked with Michael Donegan at TherapeuticsMD in 2019.